1-6 of 6
Zvenyslava Maslyak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lisaftoclax (APG-2575) Safety and Activity As Monotherapy or Combined with Acalabrutinib or Rituximab in Patients (pts) with Treatment-Naïve, Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (R/R CLL/SLL): Initial Data from a Phase 2 Global Study

Matthew S. Davids, Asher Chanan-Khan, Boyd Mudenda, Larysa Nogaieva, Iryna Kriachok, Hanna Usenko, Vladimir Ivanov, Olena Kyselova, Tetiana Perekhrestenko, Ivan Muzhychuk, Alexander Myasnikov, Zvenyslava Maslyak, Andrew Proidakov, Olga Uspenskaya, Elena Borisenkova, Paula Marlton, Tanya Siddiqi, Allison Winter, Tamila Lysa, Bulat Bakirov, Lei Fu, Zi Chen, Min Yu, Mingyu Li, Laura Glass, Mohammad Ahmad, Olena Karpenko, Iurii Osipov, Asit De, Ben Paudyal, Hengbang Wang, Robert Winkler, Nashat Gabrail, Vinod Ganju, Tatiana S. Konstantinova, Olga S. Samoylova, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2022) 140 (Supplement 1): 2326–2328.
https://doi.org/10.1182/blood-2022-160386
Published: 2022
Journal Articles

Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd)

Nizar J. Bahlis, Shambavi Richard, Darrell J. White, Sebastian Grosicki, Christine Chen, Sosana Delimpasi, Heather J. Sutherland, Zvenyslava Maslyak, Michael Sebag, Maria Gavriatopoulou, Suzanne Lentzsch, Ajai Chari, Maryana Simonova, Ivan Spicka, Iryna Kriachok, Meletios A. Dimopoulos, Halyna Pylypenko, Holger W Auner, Xavier Leleu, Ganna Usenko, Roman Hajek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P. Venner, Mamta Garg, Don Stevens, Hang Quach, Sundar Jagannath, Philippe Moreau, Moshe Levy, Ashraf Z. Badros, Larry D. Anderson, Jr., Thierry Facon, Maria-Victoria Mateos, Michele Cavo, Andrew DeCastro, Yi Chai, Dane R. Van Domelen, Moran Mishal, Ohad S. Bentur, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Paul G. Richardson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1634.
https://doi.org/10.1182/blood-2021-146324
Published: 2021
Journal Articles

Single-Agent Ibrutinib Vs Chemoimmunotherapy Regimens for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia (CLL): A Cross-Trial Comparison

Tadeusz Robak, MD PhD, Jan A. Burger, MD PhD, Alessandra Tedeschi, MD, Paul M. Barr, MD, Carolyn Jane Owen, MD FRCPC, Osnat Bairey, MD, Peter Hillmen, MBChB, PhD, David Simpson, MBChB, Sebastian Grosicki, MD PhD, Stephen Devereux, FRCP, FRCPath, PhD, Helen McCarthy, MBBS, PhD, Steven Coutre, MD, Hang Quach, MBBS, MD, Gianluca Gaidano, MD PhD, Zvenyslava Maslyak, MD, Don A Stevens, MD, Carol Moreno, MD, Devinder Gill, MD, Ian W. Flinn, MD PhD, John Gribben, MD DSc, Ahmad Mokatrin, PhD, Mei Cheng, PhD, Lori Styles, MD, Danelle F. James, MD MAS, Thomas J. Kipps, MD, Paolo Ghia, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1750.
https://doi.org/10.1182/blood.V130.Suppl_1.1750.1750
Published: 2017
Journal Articles

Results from the International, Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Patients 65 Years and Older with Treatment-Naïve CLL/SLL (RESONATE-2 TM )

Alessandra Tedeschi, MD, Paul M. Barr, MD, Tadeusz Robak, MD PhD, Carolyn Owen, MD, Paolo Ghia, MD PhD, Osnat Bairey, MD, Peter Hillmen, MB, ChB, PhD, Nancy L Bartlett, MD, Jianyong Li, MD, David Simpson, MBBS, Sebastian Grosicki, MD PhD, Stephen Devereux, FRCP, FRCPath, PhD, Helen McCarthy, FRCP, FRCPath, PhD, Steven Coutre, MD, Hang Quach, MD, Gianluca Gaidano, MD PhD, Zvenyslava Maslyak, MD, Don A. Stevens, MD, Ann Janssens, MD, Fritz Offner, MD PhD, Jiří Mayer, MD, Michael O'Dwyer, MD, Andrzej Hellmann, MD PhD, Anna Schuh, MD PhD, Tanya Siddiqi, MD, Aaron Polliack, MD, Constantine S. Tam, MBBS, Michael Keating, MBBS, Deepali Suri, MS, Cathy Zhou, MS, Fong Clow, ScD, Lori Styles, MD, Danelle F. James, MD MAS, Thomas J. Kipps, MD, PhD, Jan A. Burger, MD PhD
Journal: Blood
Blood (2015) 126 (23): 495.
https://doi.org/10.1182/blood.V126.23.495.495
Published: 2015
Journal Articles

Key Results of International Randomized Open-Label Clinical Study of BCD-020 (rituximab biosimilar candidate) in Patients with B-Cell Non-Hodgkin’s Lymphoma

Kamil Kaplanov, Andrey Zaritskiy, MD, Sergey Alexeev, MD, PhD, Elena Volodicheva, Alexander Loginov, MD, Rashida Orlova, MD, PhD, Victoria Dvornichenko, MD, PhD, Marina Kosinova, MD, Olga Serduk, Vladimir Milovanov, MD, Alexander Myasnikov, MD PhD, Shekar Patil, MD, Shekar Patil, MD, Bharath Rangarajan, MD, Senthil Jagannathan Rajappa, MD DM, Minish Jain, MD, Sharanabasappa Nirni, MD, PhD, Akhil Deka, M, Grigoriy B Rekhtman, Iryna Kryachok, Zvenyslava Maslyak, Ekaterina Chernyaeva, MD, Roman Ivanov, MD, PhD, Alexander Isaev, MD
Journal: Blood
Blood (2014) 124 (21): 5467.
https://doi.org/10.1182/blood.V124.21.5467.5467
Published: 2014
Journal Articles

The Incidence of Bcr-Abl Mutations and Their Impact on Clinical Outcome in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Bosutinib Versus Imatinib in the BELA Trial

Dong-Wook Kim, Jorge E Cortes, Zvenyslava Maslyak, Raymond Wong, Ladan Duvillie, Christine Powell, Athena Countouriotis, Tim H Brümmendorf
Journal: Blood
Blood (2011) 118 (21): 2769.
https://doi.org/10.1182/blood.V118.21.2769.2769
Published: 2011